Homocysteine in nonalcoholic steatohepatitis: seemingly a paradox revisited

Authors

  • Stergios A Polyzos First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece http://orcid.org/0000-0001-9232-4042
  • Apostolis Papaefthymiou First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • Michael Doulberis First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
  • Panagiotis Katsinelos Second Medical Clinic, School of Medicine, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece
  • Jannis Kountouras Second Medical Clinic, School of Medicine, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece

DOI:

https://doi.org/10.15403/jgld-1667

Keywords:

fibrosis, homocysteine, glutathione, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis

Downloads

Published

2020-06-04

How to Cite

1.
Polyzos SA, Papaefthymiou A, Doulberis M, Katsinelos P, Kountouras J. Homocysteine in nonalcoholic steatohepatitis: seemingly a paradox revisited. JGLD [Internet]. 2020 Jun. 4 [cited 2025 Jul. 9];29(2):270-1. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/1667

Issue

Vol. 29 No. 2: June 2020

Section

Letters